#
Tagraxofusp-erzs Intravenous
  • Drugs A to Z
  • Tagraxofusp-erzs (Intravenous)

Tagraxofusp-erzs (Intravenous)

Medically reviewed by Drugs.com. Last updated on May 22, 2022.

Intravenous route(Solution)

Capillary Leak Syndrome (CLS) which may be life-threatening or fatal, can occur in patients receiving tagraxofusp-erzs. Monitor for signs and symptoms of CLS and take actions as recommended

Commonly used brand name(s)

In the U.S.

  • Elzonris

Available Dosage Forms:

  • Solution

Therapeutic Class: Antineoplastic Agent

Uses for tagraxofusp-erzs

Tagraxofusp-erzs injection is used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN).

Tagraxofusp-erzs is to be given only by or under the direct supervision of your doctor.

Before using tagraxofusp-erzs

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For tagraxofusp-erzs, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to tagraxofusp-erzs or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of tagraxofusp-erzs injection in children 2 years of age and older. Safety and efficacy have been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of tagraxofusp-erzs injection in the elderly. However, elderly patients are more likely to have unwanted effects (eg, confusion, mental problems, dementia, encephalopathy), which may require caution in patients receiving tagraxofusp-erzs.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with food/tobacco/alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other medical problems

The presence of other medical problems may affect the use of tagraxofusp-erzs. Make sure you tell your doctor if you have any other medical problems, especially:

  • Heart problems—Use with caution. May cause side effects to become worse.
  • Liver problems—Use with caution. May make this condition worse.